These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8525661)

  • 1. [Amylin: from humans and mice].
    Fehmann HC; Göke B
    Z Gastroenterol; 1995 Sep; 33(9):551-2. PubMed ID: 8525661
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet amyloid and type 2 diabetes mellitus.
    Höppener JW; Ahrén B; Lips CJ
    N Engl J Med; 2000 Aug; 343(6):411-9. PubMed ID: 10933741
    [No Abstract]   [Full Text] [Related]  

  • 3. [S20G mutation of amylin gene--amyloid diabetes due to S20G amylin gene mutation].
    Sanke T; Sakagashira S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():160-5. PubMed ID: 15779362
    [No Abstract]   [Full Text] [Related]  

  • 4. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
    Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
    FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.
    Hayden MR; Karuparthi PR; Manrique CM; Lastra G; Habibi J; Sowers JR
    Exp Biol Med (Maywood); 2007 Jun; 232(6):772-9. PubMed ID: 17526769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of amylin in the physiologic and physiopathologic regulation of energy metabolism].
    Cooper GJ
    Journ Annu Diabetol Hotel Dieu; 1991; ():125-39. PubMed ID: 1886326
    [No Abstract]   [Full Text] [Related]  

  • 8. The pathogenesis of maturity-onset diabetes mellitus: is there a link to islet amyloid polypeptide?
    Westermark P; Johnson KH
    Bioessays; 1988 Jul; 9(1):30-3. PubMed ID: 3063263
    [No Abstract]   [Full Text] [Related]  

  • 9. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
    Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
    Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice.
    Mulder H; Mårtensson H; Sundler F; Ahrén B
    Metabolism; 2000 Dec; 49(12):1518-22. PubMed ID: 11145110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of the endocrine pancreas: the central role of amylin and insulin resistance.
    Hayden MR; Tyagi SC
    South Med J; 2000 Jan; 93(1):24-8. PubMed ID: 10653060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
    Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
    J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell mass plasticity in type 2 diabetes.
    Del Prato S; Wishner WJ; Gromada J; Schluchter BJ
    Diabetes Obes Metab; 2004 Sep; 6(5):319-31. PubMed ID: 15287924
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
    Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE
    Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "A" is for amylin and amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
    Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
    Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus.
    Hayden MR
    JOP; 2002 Sep; 3(5):126-38. PubMed ID: 12221327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.